Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1

Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1–2 trial

Published:2018-02 Issue:2 Volume:19 Page:257-266
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

O'Connor Owen A,Lue Jennifer K,Sawas Ahmed,Amengual Jennifer E,Deng Changchun,Kalac Matko,Falchi Lorenzo,Marchi Enrica,Turenne Ithamar,Lichtenstein Renee,Rojas Celeste,Francescone Mark,Schwartz Lawrence,Cheng Bin,Savage Kerry J,Villa Diego,Crump Michael,Prica Anca,Kukreti Vishal,Cremers Serge,Connors Joseph M,Kuruvilla John

Publisher

Elsevier BV

Subject

Oncology

Reference33 articles.

1. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease;Dürkop;Cell,1992

2. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells;Stein;Blood,1985

3. Lysosomal trafficking and cysteine protease metabolism confer target-specific cytotoxicity by peptide-linked anti-CD30-auristatin conjugates;Sutherland;J Biol Chem,2006

4. Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma;Younes;J Clin Oncol,2012

5. Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study;Pro;J Clin Oncol,2012

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing salvage therapy for Hodgkin lymphoma: progress and future challenges;Expert Review of Hematology;2024-06-27

2. Brentuximab vedotin therapy followed by autologous peripheral stem cell transplantation as a viable treatment option for an older adult with transformed lymphoma: a case report and literature review;Journal of International Medical Research;2024-06

3. The role of autologous stem-cell transplantation in classical Hodgkin lymphoma in the modern era;Seminars in Hematology;2024-06

4. Advances in Hodgkin Lymphoma Treatment: From Molecular Biology to Clinical Practice;Cancers;2024-05-10

5. Antibody–drug conjugates in urothelial carcinoma: scientometric analysis and clinical trials analysis;Frontiers in Oncology;2024-03-14